DNA vaccines for emerging infectious diseases: what if?

R G Whalen
Author Information
  1. R G Whalen: Centre National de la Recherche Scientifique, Paris, France. whalen@pasteur.fr

Abstract

A novel and powerful method for vaccine research, colloquially known as DNA vaccines, involves the deliberate introduction into tissues of a DNA plasmid carrying an antigen-coding gene that transfects cells in vivo and results in an immune response. DNA vaccines have several distinct advantages, which include ease of manipulation, use of a generic technology, simplicity of manufacture, and chemical and biological stability. In addition, DNA vaccines are a great leveler among re-searchers around the world because they provide unprecedented ease of experi-mentation. To facilitate diffusion of information, an Internet site has been established called THE DNA VACCINE WEB (URL:http://www.genweb.com/dnavax/dnavax.html). In this review, a brief survey is undertaken of the experimental models and preclinical work on DNA vaccines to contribute to a greater awareness of the possibilities for emerging infectious diseases.

References

  1. Science. 1990 Mar 23;247(4949 Pt 1):1465-8 [PMID: 1690918]
  2. J Virol. 1994 Sep;68(9):5685-9 [PMID: 8057449]
  3. Proc Natl Acad Sci U S A. 1993 May 1;90(9):4156-60 [PMID: 8483929]
  4. Hum Gene Ther. 1993 Apr;4(2):151-9 [PMID: 8494924]
  5. J Virol. 1993 Sep;67(9):5664-7 [PMID: 8350420]
  6. Vaccine. 1993;11(9):957-60 [PMID: 8212843]
  7. DNA Cell Biol. 1993 Nov;12(9):771-6 [PMID: 7692877]
  8. DNA Cell Biol. 1993 Nov;12(9):777-83 [PMID: 8216848]
  9. DNA Cell Biol. 1993 Nov;12(9):785-9 [PMID: 8216849]
  10. DNA Cell Biol. 1993 Nov;12(9):791-7 [PMID: 8216850]
  11. Proc Natl Acad Sci U S A. 1994 Sep 27;91(20):9519-23 [PMID: 7937799]
  12. Proc Natl Acad Sci U S A. 1994 Oct 11;91(21):9866-70 [PMID: 7937907]
  13. Vaccine. 1994 Dec;12(16):1503-9 [PMID: 7879414]
  14. Vaccine. 1994 Dec;12(16):1529-33 [PMID: 7879419]
  15. Vaccine. 1994 Dec;12(16):1537-40 [PMID: 7879421]
  16. Clin Immunol Immunopathol. 1995 Apr;75(1):1-12 [PMID: 7882589]
  17. J Virol. 1995 Apr;69(4):2574-82 [PMID: 7884908]
  18. J Virol. 1995 Apr;69(4):2684-8 [PMID: 7884923]
  19. Immunity. 1995 Feb;2(2):129-35 [PMID: 7895169]
  20. J Immunol. 1995 Apr 15;154(8):4010-7 [PMID: 7706740]
  21. Virology. 1995 May 10;209(1):147-54 [PMID: 7747464]
  22. Immunology. 1995 Feb;84(2):173-6 [PMID: 7750991]
  23. Proc Natl Acad Sci U S A. 1995 Jun 6;92(12):5307-11 [PMID: 7777503]
  24. Virology. 1995 Jun 1;209(2):569-79 [PMID: 7778289]
  25. J Immunol. 1995 Jul 1;155(1):259-65 [PMID: 7602102]
  26. Biochem Biophys Res Commun. 1995 Jul 26;212(3):1029-39 [PMID: 7626089]
  27. DNA Cell Biol. 1995 Jul;14(7):643-51 [PMID: 7626224]
  28. J Immunol. 1995 Aug 15;155(4):2039-46 [PMID: 7636255]
  29. J Virol. 1995 Sep;69(9):5798-805 [PMID: 7637024]
  30. J Virol. 1995 Sep;69(9):5859-63 [PMID: 7637033]
  31. Virology. 1995 Aug 1;211(1):102-12 [PMID: 7645204]
  32. J Virol. 1995 Oct;69(10):5929-34 [PMID: 7666497]
  33. Nature. 1995 Oct 19;377(6550):632-5 [PMID: 7566175]
  34. Nat Med. 1995 Jun;1(6):583-7 [PMID: 7585127]
  35. Nat Med. 1995 Dec;1(12):1221 [PMID: 7489385]
  36. J Virol. 1996 Jan;70(1):678-81 [PMID: 8523593]
  37. Antiviral Res. 1995 Oct;28(2):147-57 [PMID: 8585768]
  38. Hum Gene Ther. 1995 Nov;6(11):1447-56 [PMID: 8573617]
  39. J Infect Dis. 1996 Feb;173(2):314-20 [PMID: 8568291]
  40. J Immunol. 1996 May 15;156(10):3687-95 [PMID: 8621903]
  41. Nat Med. 1996 May;2(5):540-4 [PMID: 8616712]
  42. DNA Cell Biol. 1993 Nov;12(9):799-805 [PMID: 8216851]
  43. Proc Natl Acad Sci U S A. 1993 Dec 15;90(24):11478-82 [PMID: 8265577]
  44. Hum Mol Genet. 1993 Nov;2(11):1847-51 [PMID: 8281146]
  45. Virology. 1994 Feb 15;199(1):132-40 [PMID: 8116236]
  46. Hum Gene Ther. 1993 Dec;4(6):733-40 [PMID: 8186288]
  47. Science. 1993 Mar 19;259(5102):1745-9 [PMID: 8456302]

MeSH Term

Animals
Communicable Disease Control
Communicable Diseases
Disease Models, Animal
Humans
Research
Vaccines, DNA

Chemicals

Vaccines, DNA

Word Cloud

Created with Highcharts 10.0.0DNAvaccineseaseemerginginfectiousnovelpowerfulmethodvaccineresearchcolloquiallyknowninvolvesdeliberateintroductiontissuesplasmidcarryingantigen-codinggenetransfectscellsvivoresultsimmuneresponseseveraldistinctadvantagesincludemanipulationusegenerictechnologysimplicitymanufacturechemicalbiologicalstabilityadditiongreatleveleramongre-searchersaroundworldprovideunprecedentedexperi-mentationfacilitatediffusioninformationInternetsiteestablishedcalledTHEVACCINEWEBURL:http://wwwgenwebcom/dnavax/dnavaxhtmlreviewbriefsurveyundertakenexperimentalmodelspreclinicalworkcontributegreaterawarenesspossibilitiesdiseasesdiseases:if?

Similar Articles

Cited By (17)